Clinical Trial Update: A Phase 1 Study of the Safety, Tolerability and Pharmacokinetics of ABT-126 in Subjects With Alzheimer's Disease [Phase 1]

View source ↗

Summary

Abbott's ABT-126 was studied in a Phase 1 trial in patients with Alzheimer's disease to assess safety, tolerability, and pharmacokinetics; the study has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• ABT-126

Snippet

Sponsor: Abbott | Conditions: Alzheimer's Disease | Phase 1 | Status: COMPLETED